Ya-Chea Tsai

Johns Hopkins University — United States

Immunology and Microbiology · Life Sciences

17h-index1.3kcitations94works3.62yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(54), Cervical Cancer and HPV Research(31), Cancer Immunotherapy and Biomarkers(21), Hepatitis B Virus Studies(19), Immune Cell Function and Interaction(16)

Publications94 total

Type I Interferon Modulates the Function of Ly6C High-Expressing Naïve CD8+ T Cells to Promote an Antitumor Response
Vaccines·2025· 4 citedOpen Access
Clinicopathologic Features and Viral Status of Low-risk HPV6 and HPV11-Associated Squamous Cell Carcinoma of the Uterine Cervix and Vulva
The American Journal of Surgical Pathology·2025· 4 citedOpen Access
Electroporation-mediated novel albumin-fused Flt3L DNA delivery promotes cDC1-associated anticancer immunity
Gene Therapy·2024· 1 cited
Arginine-linked HPV-associated E7 displaying bacteria-derived outer membrane vesicles as a potent antigen-specific cancer vaccine
Journal of Translational Medicine·2024· 8 citedOpen Access
STAT1-Deficient HPV E6/E7-Associated Cancers Maintain Host Immunocompetency against Therapeutic Intervention
Vaccines·2024· 1 citedOpen Access
<i>Salmonella</i> immunotherapy engineered with highly efficient tumor antigen coating establishes antigen-specific CD8+ T cell immunity and increases in antitumor efficacy with type I interferon combination therapy
OncoImmunology·2023· 15 citedOpen Access
Immune responses, therapeutic anti-tumor effects, and tolerability upon therapeutic HPV16/18 E6/E7 DNA vaccination via needle-free biojector
mBio·2023· 6 citedOpen Access
SSupplementary Figure 1 from Toll-like Receptor Agonist Imiquimod Facilitates Antigen-Specific CD8&lt;sup&gt;+&lt;/sup&gt; T-cell Accumulation in the Genital Tract Leading to Tumor Control through IFNγ
2023Open Access
Supplementary Figure 1 from Local HPV Recombinant Vaccinia Boost Following Priming with an HPV DNA Vaccine Enhances Local HPV-Specific CD8&lt;sup&gt;+&lt;/sup&gt; T-cell–Mediated Tumor Control in the Genital Tract
2023Open Access
Supplemental Figure 1 from Toll-like Receptor Agonist Imiquimod Facilitates Antigen-Specific CD8&lt;sup&gt;+&lt;/sup&gt; T-cell Accumulation in the Genital Tract Leading to Tumor Control through IFNγ
2023Open Access
Supplementary Figure 3 from Local HPV Recombinant Vaccinia Boost Following Priming with an HPV DNA Vaccine Enhances Local HPV-Specific CD8&lt;sup&gt;+&lt;/sup&gt; T-cell–Mediated Tumor Control in the Genital Tract
2023Open Access
Data from Toll-like Receptor Agonist Imiquimod Facilitates Antigen-Specific CD8&lt;sup&gt;+&lt;/sup&gt; T-cell Accumulation in the Genital Tract Leading to Tumor Control through IFNγ
2023Open Access
Supplementary Figure 4 from Local HPV Recombinant Vaccinia Boost Following Priming with an HPV DNA Vaccine Enhances Local HPV-Specific CD8&lt;sup&gt;+&lt;/sup&gt; T-cell–Mediated Tumor Control in the Genital Tract
2023Open Access
Supplementary Figure 5 from Local HPV Recombinant Vaccinia Boost Following Priming with an HPV DNA Vaccine Enhances Local HPV-Specific CD8&lt;sup&gt;+&lt;/sup&gt; T-cell–Mediated Tumor Control in the Genital Tract
2023Open Access
Supplemental Figure 1 from Toll-like Receptor Agonist Imiquimod Facilitates Antigen-Specific CD8&lt;sup&gt;+&lt;/sup&gt; T-cell Accumulation in the Genital Tract Leading to Tumor Control through IFNγ
2023Open Access
Supplemental Figure Legend from Toll-like Receptor Agonist Imiquimod Facilitates Antigen-Specific CD8&lt;sup&gt;+&lt;/sup&gt; T-cell Accumulation in the Genital Tract Leading to Tumor Control through IFNγ
2023Open Access
Supplementary Figure 1 from Local HPV Recombinant Vaccinia Boost Following Priming with an HPV DNA Vaccine Enhances Local HPV-Specific CD8&lt;sup&gt;+&lt;/sup&gt; T-cell–Mediated Tumor Control in the Genital Tract
2023Open Access
Data from Local HPV Recombinant Vaccinia Boost Following Priming with an HPV DNA Vaccine Enhances Local HPV-Specific CD8&lt;sup&gt;+&lt;/sup&gt; T-cell–Mediated Tumor Control in the Genital Tract
2023Open Access
Supplementary Figure Legends from Toll-like Receptor Agonist Imiquimod Facilitates Antigen-Specific CD8&lt;sup&gt;+&lt;/sup&gt; T-cell Accumulation in the Genital Tract Leading to Tumor Control through IFNγ
2023Open Access
Supplementary Figure 7 and 8 from Local HPV Recombinant Vaccinia Boost Following Priming with an HPV DNA Vaccine Enhances Local HPV-Specific CD8&lt;sup&gt;+&lt;/sup&gt; T-cell–Mediated Tumor Control in the Genital Tract
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Chien‐Fu Hung(41), Liangmei He(24), T.‐C. Wu(22), Shiwen Peng(15), Richard B.S. Roden(14), Cornelia L. Trimble(12), Liwen Song(9), Benjamin Yang(8), T.-C. Wu(8), Deyin Xing(6), Warner K. Huh(5), Janson Trieu(5), Jayne Knoff(5), Michelle Y. Cheng(5), Ching-Yen Ho(5), Ming‐Hung Hu(5), Hsin-Fang Tu(5), Wen‐Fang Cheng(4), Andrew Yang(4), Tae Heung Kang(4)